TRICARE Meth Rehabs
Reviewed and updated: July 22, 2026
TriCareRehabs.com is an independent educational referral and helpline service, not a treatment provider, law firm, military program, government agency, or TRICARE.
DIRECT ANSWER
Does TRICARE cover methamphetamine rehab?
TRICARE may cover medically necessary treatment for methamphetamine or other stimulant use disorders. Care may include outpatient, intensive outpatient, partial hospitalization, residential, or inpatient services based on clinical need. Unlike opioid or alcohol use disorders, there is currently no FDA-approved medication specifically for stimulant use disorder.
- Stimulant withdrawal often involves a crash, sleep disruption, depression, and craving.
- Psychosis, chest pain, severe agitation, or suicidal thinking may require emergency care.
- Contingency management and other behavioral treatments are important program capabilities.
Methamphetamine Treatment Has Different Clinical Priorities
Methamphetamine is a potent stimulant. Treatment planning must consider cardiovascular symptoms, sleep deprivation, nutrition, dental and skin concerns, paranoia or psychosis, depression, trauma, and use of opioids or other substances. A generic sedative or opioid detox template does not address these needs.
Some people need a medically supported setting because of acute psychiatric symptoms, severe agitation, suicidal thinking, dehydration, or heart-related concerns. Others can begin structured outpatient care. The decision depends on current symptoms and environmental safety, not simply the substance name.
What Stimulant Withdrawal Can Look Like
After stopping methamphetamine, a person may experience extreme fatigue, increased sleep, disrupted sleep later, low mood, anxiety, slowed thinking, increased appetite, and intense craving. Unlike alcohol or benzodiazepine withdrawal, the main danger is not usually a predictable seizure syndrome; however, severe depression, suicidality, psychosis, or medical complications can make the situation urgent.
Evidence-Based Program Features to Ask About
| Feature | Why it matters for methamphetamine use |
|---|---|
| Contingency management | This behavioral intervention has demonstrated effectiveness for stimulant use disorders. |
| Cognitive and motivational therapies | They can address triggers, decision-making, coping, and engagement. |
| Psychiatric assessment | Depression, anxiety, trauma, ADHD, sleep problems, and psychosis may need coordinated care. |
| Opioid and fentanyl screening | Some stimulant supplies contain opioids, and co-use changes overdose planning. |
| Longer-term follow-up | Craving, anhedonia, sleep disruption, and functional recovery can persist after the initial crash. |
No FDA-Approved Stimulant-Use-Disorder Medication
There is currently no FDA-approved medication specifically for methamphetamine or stimulant use disorder. Clinicians may still treat co-occurring symptoms and medical conditions. Marketing a medication as a guaranteed meth cure would be inaccurate. Program quality should be judged by evidence-based behavioral care, psychiatric and medical capability, retention strategies, and continuing support.
Military and TRICARE Verification
Active-duty members may enter care through ADAPT, Navy SARP, Army SUDCC, or the corresponding Service pathway. Treatment and legal questions should be kept distinct when drug-testing or disciplinary concerns exist. For a civilian program, verify the requested level, referral or pre-authorization, provider authorization, network status, and ability to treat stimulant-specific psychiatric risks.
If the concern is substance use—not only methamphetamine treatment
Use the official military or TRICARE pathway first when it fits your situation. A licensed clinician should assess safety, withdrawal risk, diagnosis, and the appropriate level of care. A clinician should assess acute psychiatric and cardiovascular risk. Active-duty members can use the applicable Service substance-use program for official evaluation and referral.
If you also want to discuss potential civilian treatment-provider options, call the independent TriCareRehabs.com referral helpline.
Call 855-720-0540 to Discuss Provider Options
Calls are answered by South Shores Recovery, a treatment provider. TriCareRehabs.com is not a treatment provider, legal service, military program, or part of TRICARE. Benefits, costs, authorization, admission, placement, confidentiality limits, and career outcomes are not guaranteed.
Frequently Asked Questions
Is there an FDA-approved medication for methamphetamine use disorder?
No medication is currently FDA-approved specifically for stimulant use disorder, although clinicians can treat co-occurring medical and psychiatric conditions.
Does methamphetamine withdrawal require inpatient detox?
Not everyone requires inpatient care. Severe depression, suicidality, psychosis, medical instability, or an unsafe environment can support a higher level of care.
What treatment has evidence for stimulant use disorder?
Behavioral approaches—including contingency management—are important evidence-based components of stimulant treatment.
Primary sources and further reading
- TRICARE Substance Use Disorder Treatment
- NIDA: Methamphetamine
- SAMHSA: Treatment of Stimulant Use Disorders
- SAMHSA Contingency Management Advisory
Military policies, benefit rules, provider networks, and clinical guidance can change. Verify current requirements with the applicable official program, TRICARE, and a licensed professional.
855-720-0540